Trials / Completed
CompletedNCT02912533
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Kissei Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to investigate the safety and efficacy for 52-week dosing of JR-131 in renal anemia patients with chronic kidney disease (CKD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JR-131 |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-09-23
- Last updated
- 2019-04-02
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02912533. Inclusion in this directory is not an endorsement.